Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03781765
PHASE4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Sponsor: Icahn School of Medicine at Mount Sinai
View on ClinicalTrials.gov
Summary
The study team will examine the effects of FDA approved stimulant and non-stimulant medications for ADHD, among youth with ADHD and with and without Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.
Key Details
Gender
All
Age Range
7 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2019-06-04
Completion Date
2025-09-25
Last Updated
2024-08-09
Healthy Volunteers
No
Interventions
DRUG
Methylphenidate
stimulant medication
DRUG
Atomoxetine
non-stimulant medication
Locations (1)
Icahn School of Medicine at Mount Sinai
New York, New York, United States